Bartz S.R., Rogel M.E., Emerman, M.: Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol., 1996, 70, 2324-2331.
Bischoff J.R., Kirn D.H., Williams A., Heise C., Horn S., Muna M., Ng L., Nye J.A., Sampson-Johannes A., Fattaey A., McCormick F.: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science, 1996, 274, 373-376.
Bukrinsky M., Adzhubei A.: Viral protein R of HIV-1. Rev. Med. Virol., 1999, 9, 39-49.
Chebloune Y., Karr B., Sheffer D., Leung K., Narayan O.: Variations in lentiviral gene expression in monocyte-derived macrophages from naturally infected sheep. J. Gen. Virol., 1996, 77, 2037-2051.
Chebloune Y., Karr B., Singh D.K., Narayan, O.: Visna virus. Persistent viral infections, New York, Edited by Raft Ahmed and Irvin S.Y. Chen. 1999, 347-362.
Chebloune Y., Sheffer D., Karr B.M., Stephens E., Narayan O.: Restrictive type of replication of ovine/caprine lentiviruses in ovine fibroblast cell cultures. Virology, 1996, 222, 21-30.
Chen J., Lin J., Levine A.J.: Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med., 1995, 1, 142-152.
Chen J., Wu X., Lin J., Levine A.J.: mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell Biol., 1996, 16, 2445-2452.
Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A.: Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol., 1990, 64, 3097-3099.
Debs R.J., Fuchs H.J., Philip R., Brunette E.N., Duzgunes N., Shellito J.E., Liggitt D., Patton J.R.: Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats. Cancer Res., 1990, 50, 375-380.
Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R.: Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immuno-deficiency virus type 1 Vpr. J. Virol., 1995, 69, 7909-7916.
Fletcher T.M., Brichacek B., Sharova N., Newman M.A., Stivahtis G., Sharp P.M., Emerman M., Hahn B.H., Stevenson M. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J., 1996, 15, 6155-6165.
Gorrell M.D., Brandon M.R., Sheffer D., Adams R.J., Narayan O.: Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes. J. Virol., 1992, 66, 2679-2688.
He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol., 1995, 69, 6705-6711.
Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M.: The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 7311-7315.
Herr I., Wilhelm D., Bohler T., Angel P., Debatin K.M.: Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J., 1997, 16, 6200-6208.
Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., Chen I.S.: The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol., 1995, 69, 6304-6313.
Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W.: Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 1991a, 51, 6304-6311.
Kastan M.B., Radin A.I., Kuerbitz S.J., Onyekwere O., Wolkow C.A., Civin C.I., Stone K.D., Woo T., Ravindranath Y., Craig R.W.: Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 1991b, 51, 4279-4286.
Kawabe T., Muslin A.J., Korsmeyer S.J.: HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature, 1997, 385, 454-458.
Levine A.J.: p53, the cellular gatekeeper for growth and division. Cell., 1997, 88, 323-331.
Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., Weiner D.B.: Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol., 1997, 71, 6339-6347.
McDonnell T.J. Korsmeyer S.J.: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature, 1991. 349, 254-256.
Mesri M., Wall N.R., Li J., Kim R.W., Altieri D.C.: Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest., 2001,108, 981-990.
Motwani M., Delohery T.M., Schwartz G.K.: Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin. Cancer Res., 1999, 5, 1876-1883.
Mselli-Lakhal L., Favier C., Leung K., Guiguen F., Grezel D., Miossec P., Mornex J.F., Narayan O., Querat G., Chebloune Y.: Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells. J. Virol., 2000, 74, 8343-8348.
Naik P., Karrim J., Hanahan D.: The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 1996, 10, 2105-2116.
Narayan O., Clements J.E., Strandberg J.D., Cork L.C., Griffin D.E.: Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J. Gen. Virol., 1980, 50, 69-79.
Nemunaitis J., Khuri F., Ganly I., Arseneau J., Posner M., Vokes E., Kuhn J., McCarty T., Landers S., Blackburn A., Romel L., Randlev B., Kaye S., Kirn D. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J. Clin. Oncol., 2001, 19, 289-298.
Nunez G., Hockenbery D., McDonnell T.J., Sorensen C.M., Korsmeyer S.J.: Bcl-2 maintains B cell memory. Nature, 1991, 353, 71-73.
Pancio H.A., Vander H.N., Kosuri K., Cresswell P., Ratner L.: Interaction of human immunodeficiency virus type 2 Vpx and invariant chain. J. Virol., 2000, 74, 6168-6172.
Patel C.A., Mukhtar M., and Pomerantz R.J.: Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol., 2000, 74, 9717-9726.
Perry M.E. Levine A.J.: P53 and mdm-2: interactions between tumor suppressor gene and oncogene products. Mr. Sinai. J. Med., 1994, 61, 291-299.
Planelles V., Jowett J.B., Li Q.X., Xie Y., Hahn B., Chen I.S.: Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol., 1996, 70, 2516-2524.
Re F., Braaten D., Franke E.K., Luban J.: Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol., 1995, 69, 6859-6864.
Rogel M.E., Wu L.I., Emerman M.: The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol., 1995, 69, 882-888.
Rowinsky E.K.: The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med., 1997, 48, 353-374.
Schreiber M., Muller W.J., Singh G., Graham F.L.: Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene, 1999, 18, 1663-1676.
Silva Teixeira M.F., Lambert V., Mselli-Lakahl L., Chettab A., Chebloune Y., Mornex J.F.: Immortalization of caprine fibroblasts permissive for replication of small ruminant lentiviruses. Am. J. Vet. Res., 1997, 58, 579-584.
Singh D.K., Chebloune Y., Mselli-Lakhal L., Karr B.M., Narayan O.: Ovine lentivirus-infected macrophages mediate productive infection in cell types that are not susceptible to infection with cell-free virus. J. Gen. Virol., 1999, 80, 1437-1444.
Steller H.: Mechanisms and genes of cellular suicide. Science., 1995, 267, 1445-1449.
Stewart S.A., Poon B., Jowett J.B., Chen I.S.: Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol., 1997, 71, 5579-5592.
Stewart S.A., Poon B., Jowett J.B., Xie Y., Chen I.S.:. Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 12039-12043.
Thompson C.B.: Apoptosis in the pathogenesis and treatment of disease. Science, 1995, 267, 1456-1462.
Xiong Y., Zhang H., Beach D.:. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 1993, 7, 1572-1583.
Yao X.J., Mouland A.J., Subbramanian R.A., Forget J., Rougeau N., Bergeron D., Cohen, E.A.: Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J. Virol., 1998, 72, 4686-4693.
Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T.H.: Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses, 1990, 6, 1265-1271.
Zhang L., Huang Y., Yuan H., Tuttleton S., Ho D.D.: Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology, 1997, 228, 340-349.
Zhao Y., Cao J., O'Gorman M.R., Yu M., Yogev R.: Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J. Virol., 1996, 70, 5821-5826.
